Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry

被引:10
|
作者
Zubaid, Mohammad [1 ]
Khraishah, Haitham [2 ]
Alahmad, Barrak [3 ]
Rashed, Wafa [4 ]
Ridha, Mustafa [5 ]
Alenezi, Fahad [6 ]
Aljarralah, Mohamad [7 ]
Al-Marri, Khalid [8 ]
Almutairi, Mohammad [9 ]
Althalji, Khalid [6 ]
Alfaddagh, Abdulhamied [10 ]
机构
[1] Kuwait Univ, Fac Med, Dept Med, Kuwait, Kuwait
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, TH Chan Sch Publ Hlth, Environm Hlth Dept, Boston, MA 02115 USA
[4] Minist Hlth, Dept Med, Div Cardiol, Mubarak Alkabeer Hosp, Kuwait, Kuwait
[5] Minist Hlth, Dept Cardiol, Salman Aldabous Cardiac Ctr, Kuwait, Kuwait
[6] Minist Hlth, Dept Med, Div Cardiol, Alfarwaniya Hosp, Kuwait, Kuwait
[7] Minist Hlth, Dept Cardiol, Sabah Alahmad Cardiac Ctr, Kuwait, Kuwait
[8] Minist Hlth, Dept Cardiol, Chest Dis Hosp, Kuwait, Kuwait
[9] Aljahra Hosp, Dept Med, Div Cardiol, Kuwait, Kuwait
[10] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Baltimore, MD USA
来源
ANNALS OF GLOBAL HEALTH | 2020年 / 86卷 / 01期
关键词
GULF REGISTRY; TASK-FORCE; REPERFUSION; OUTCOMES; DELAYS; FIBRINOLYSIS; GUIDELINES; EXPERIENCE; TRENDS; PCI;
D O I
10.5334/aogh.2632
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: A pharmacoinvasive reperfusion strategy is recommended for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (PCI) cannot be achieved in a timely fashion. This is based on a limited number of trials. The effectiveness of this strategy in the real-world is unclear. Objectives: To compare the effectiveness of pharmacoinvasive strategy versus primary PCI using a nationwide prospective registry of STEMI patients. Methods: We examined 936 STEMI patients from the reperfusion in ST-elevation myocardial infarction in Kuwait (REPERFUSE Kuwait) registry who underwent either primary PCI or pharmacoinvasive reperfusion. A composite outcome was measured based on death, congestive heart failure, reinfarction or stroke prospectively ascertained during hospital stay and up to one-year follow-up. The association between reperfusion strategy and the composite outcome was assessed using multivariate regression and Poisson proportional hazard model. Results: Compared to the pharmacoinvasive group, those undergoing primary PCI had higher Killip class on presentation and required more blood transfusions during hospitalization. There was no significant difference between primary PCI and pharmacoinvasive strategy with regards to the incidence of the composite outcome during the in-hospital period (RR = 1.0; 95% CI 0.98-1.02; p = 0.96) after adjustment for possible confounders. Over one-year follow-up, the survival of the two groups was not different (p = 0.66). The incidence of major bleeding was similar in both groups. Conclusion: STEMI patients treated with a pharmacoinvasive strategy have comparable outcomes to those treated with primary PCI with no increased risk of major bleeding. These real-world data support the use of a pharmacoinvasive strategy when primary PCI cannot be achieved in a timely fashion.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Efficacy And Safety Of Pharmacoinvasive Strategy Compared To Primary Percutaneous Coronary Intervention In The Management Of St-segment Elevation Myocardial Infarction: A Prospective Country-wide Registry
    Khraishah, Haitham
    Alahmad, Barrak
    Alfaddagh, Abdulhamied
    Zubaid, Mohammad
    CIRCULATION, 2019, 140
  • [2] Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country
    Manuel Chacón-Diaz
    Piero Custodio-Sánchez
    Paol Rojas De la Cuba
    Germán Yábar-Galindo
    René Rodríguez-Olivares
    David Miranda-Noé
    Luis Marcos López-Rojas
    Akram Hernández-Vásquez
    BMC Cardiovascular Disorders, 22
  • [3] Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country
    Chacon-Diaz, Manuel
    Custodio-Sanchez, Piero
    Rojas de la Cuba, Paol
    Yabar-Galindo, German
    Rodriguez-Olivares, Rene
    Miranda-Noe, David
    Lopez-Rojas, Luis Marcos
    Hernandez-Vasquez, Akram
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [4] Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System
    Rashid, Mohammed K.
    Guron, Nita
    Bernick, Jordan
    Wells, George A.
    Blondeau, Melissa
    Chong, Aun-Yeong
    Dick, Alexander
    Froeschl, Michael P. V.
    Glover, Chris A.
    Hibbert, Benjamin
    Labinaz, Marino
    Marquis, Jean-Francois
    Osborne, Christina
    So, Derek Y.
    Le May, Michel R.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (19) : 2014 - 2020
  • [5] Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Patients ≥70 Years of Age
    Auffret, Vincent
    Laurin, Clement
    Leurent, Guillaume
    Didier, Romain
    Filippi, Emmanuelle
    Hacot, Jean-Philippe
    Zabalawi, Amer
    Rouault, Gilles
    Saouli, Djamel
    Druelles, Philippe
    Coudert, Isabelle
    Boulanger, Bertrand
    Bot, Emilie
    Treuil, Josiane
    Bedossa, Marc
    Boulmier, Dominique
    Loirat, Aurelie
    Sharobeem, Sam
    Le Guellec, Marielle
    Gilard, Martine
    Le Breton, Herve
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (01): : 1 - 10
  • [6] Percutaneous coronary intervention in ST-segment elevation myocardial infarction
    Kimura K.
    Kosuge M.
    Okuda J.
    Cardiovascular Intervention and Therapeutics, 2010, 25 (2) : 53 - 59
  • [7] Primary Percutaneous Coronary Angioplasty With and Without Eptifibatide in ST-Segment Elevation Myocardial Infarction A Safety and Efficacy Study of Integrilin-Facilitated Versus Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (ASSIST)
    Le May, Michel R.
    Wells, George A.
    Glover, Chris A.
    So, Derek Y.
    Froeschl, Michael
    Marquis, Jean-Francois
    O'Brien, Edward R.
    Turek, Michele
    Thomas, Allyson
    Kass, Malek
    Jadhav, Sachin
    Labinaz, Marino
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (04) : 330 - 338
  • [8] Primary Percutaneous Coronary Intervention as a National Reperfusion Strategy in Patients With ST-Segment Elevation Myocardial Infarction
    Terkelsen, Christian J.
    Jensen, Lisette O.
    Tilsted, Hans H.
    Thaysen, Per
    Ravkilde, Jan
    Johnsen, Soren P.
    Trautner, Sven
    Andersen, Henning R.
    Thuesen, Leif
    Lassen, Jens F.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (06) : 570 - 576
  • [9] Alternative stents in ST-segment elevation myocardial infarction: improving the efficacy of primary percutaneous coronary intervention
    Yetgin, Tuncay
    Nakatani, Shimpei
    Onuma, Yoshinobu
    van Geuns, Robert-Jan M.
    FUTURE CARDIOLOGY, 2015, 11 (03) : 347 - 357
  • [10] Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
    Kikkert, Wouter J.
    Hoebers, Loes P.
    Damman, Peter
    Lieve, Krystien V. V.
    Claessen, Bimmer E. P. M.
    Vis, Marije M.
    Baan, Jan, Jr.
    Koch, Karel T.
    de Winter, Robbert J.
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (02): : 229 - 235